The FLIP-side of fas signalingHYER, Marc L; SAMUEL, Temesgen; REED, John C et al.Clinical cancer research. 2006, Vol 12, Num 20, pp 5929-5931, issn 1078-0432, 3 p., 1Article

Switch from Type II to I Fas/CD95 Death Signaling on In Vitro Culturing of Primary HepatocytesWALTER, Dorothée; SCHMICH, Kathrin; MERFORT, Irmgard et al.Hepatology (Baltimore, Md.). 2008, Vol 48, Num 6, pp 1942-1953, issn 0270-9139, 12 p.Article

Construction of Optimized Bispecific Antibodies for Selective Activation of the Death Receptor CD95HERRMANN, Tanja; GROSSE-HOVEST, Ludger; OTZ, Tina et al.Cancer research (Baltimore). 2008, Vol 68, Num 4, pp 1221-1227, issn 0008-5472, 7 p.Article

Cell-permeable small compounds that modulate Fas-mediated apoptosisKATAOKA, Takao.Recent research developments in biochemistry (Vol. 5 (2004)). Recent research developments in biochemistry. 2004, pp 129-140, isbn 81-271-0049-8, 12 p.Book Chapter

Fas pulls the trigger on psoriasisGILHAR, Amos; YANIV, Ron; ASSY, Bedia et al.The American journal of pathology. 2006, Vol 168, Num 1, pp 170-175, issn 0002-9440, 6 p.Article

Protective effects of diosmetin extracted from Galium verum L. on the thymus of U14-bearing miceRUI ZHAO; ZHIBAO CHEN; GUIYAN JIA et al.Canadian journal of physiology and pharmacology. 2011, Vol 89, Num 9, pp 665-673, issn 0008-4212, 9 p.Article

Regulation of Fas-mediated immune homeostasis by an activation-induced protein, CyclonSAINT FLEUR, Shella; HOSHINO, Akemi; KONDO, Kimie et al.Blood. 2009, Vol 114, Num 7, pp 1355-1365, issn 0006-4971, 11 p.Article

The Small Ubiquitin-like Modifier Mediates the Resistance of Prosthesis-Loosening Fibroblast-like Synoviocytes Against Fas-Induced ApoptosisMEINECKE, Ingmar; PAP, Géza; PAP, Thomas et al.Arthritis and rheumatism. 2009, Vol 60, Num 7, pp 2065-2070, issn 0004-3591, 6 p.Article

Dominant-negative fas mutation is reversed by down-expression of c-FLIPBENETEAU, Marie; DABURON, Sophie; MOREAU, Jean-Francois et al.Cancer research (Baltimore). 2007, Vol 67, Num 1, pp 108-115, issn 0008-5472, 8 p.Article

Lack of UCP2 reduces fas-mediated liver injury in ob/ob mice and reveals importance of cell-specific UCP2 expressionFÜLÖP, Péter; DERDAK, Zoltan; SHEETS, Anthony et al.Hepatology (Baltimore, Md.). 2006, Vol 44, Num 3, pp 592-601, issn 0270-9139, 10 p.Article

Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS UpregulationJIANQIANG WU; NIHAL, Minakshi; SIDDIQUI, Jawed et al.Journal of investigative dermatology. 2009, Vol 129, Num 5, pp 1165-1173, issn 0022-202X, 9 p.Article

Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammationCAPRIOLI, F; STOLFI, C; CARUSO, R et al.Gut. 2008, Vol 57, Num 12, pp 1674-1680, issn 0017-5749, 7 p.Article

PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivoTAO, Rong-Hua; BERKOVA, Zuzana; SAMANIEGO, Felipe et al.Blood. 2011, Vol 118, Num 11, pp 3107-3118, issn 0006-4971, 12 p.Article

Autoimmune lymphoproliferative syndrome with somatic Fas mutationsHOLZELOVA, Eliska; VONARBOURG, Cédric; LE DEIST, Francoise et al.The New England journal of medicine. 2004, Vol 351, Num 14, pp 1409-1418, issn 0028-4793, 10 p.Article

A role for the Fas/FasL system in modulating genetic susceptibility to T-cell lymphoblastic lymphomasVILLA-MORALES, Maria; SANTOS, Javier; PEREZ-GOMEZ, Eduardo et al.Cancer research (Baltimore). 2007, Vol 67, Num 11, pp 5107-5116, issn 0008-5472, 10 p.Article

Assignment of the human Fas antigen gene (FAS) to 10q24.1INAZAWA, J; ITOH, N; ABE, T et al.Genomics (San Diego, Calif.). 1992, Vol 14, Num 3, pp 821-822, issn 0888-7543Article

Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathwaysFUKUMORI, Tomoharu; TAKENAKA, Yukinori; OKA, Natsuo et al.Cancer research (Baltimore). 2004, Vol 64, Num 10, pp 3376-3379, issn 0008-5472, 4 p.Article

Loss of the Nf1 tumor suppressor gene decreases Fas antigen expression in myeloid cellsHIATT, Kelly; INGRAM, David A; HUDDLESTON, Hannah et al.The American journal of pathology. 2004, Vol 164, Num 4, pp 1471-1479, issn 0002-9440, 9 p.Article

Osteoclast apoptosis: The role of Fas in vivo and in vitroXIAOJUN WU; MCKENNA, Margaret A; XU FENG et al.Endocrinology (Philadelphia). 2003, Vol 144, Num 12, pp 5545-5555, issn 0013-7227, 11 p.Article

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasLSINHA, Pratima; CHORNOGUZ, Olesya; CLEMENTS, Virginia K et al.Blood. 2011, Vol 117, Num 20, pp 5381-5390, issn 0006-4971, 10 p.Article

UPREGULATION OF FAS AND FASL EXPRESSION IN NICOTINE-INDUCED APOPTOSIS OF ENDOTHELIAL CELLSCHENG, X. L; ZHANG, H; GUO, D et al.Methods and findings in experimental and clinical pharmacology. 2010, Vol 32, Num 1, pp 13-18, issn 0379-0355, 6 p.Article

Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and DaxxGADDY, Daniel F; LYLES, Douglas S.Journal of virology. 2007, Vol 81, Num 6, pp 2792-2804, issn 0022-538X, 13 p.Article

Fas polymorphisms influence susceptibility to autoimmune hepatitisHIRAIDE, Akira; IMAZEKI, Fumio; YOKOSUKA, Osamu et al.The American journal of gastroenterology. 2005, Vol 100, Num 6, pp 1322-1329, issn 0002-9270, 8 p.Article

IL-4-induced apoptosis in peripheral blood eosinophilsWEDI, B; RAAP, U; LEWRICK, H et al.Journal of allergy and clinical immunology. 1998, Vol 102, Num 6, pp 1013-1020, issn 0091-6749, 1Article

Apoptosis, haemopoiesis and leukaemogenesisEKERT, P. G; VAUX, D. L.Baillière's clinical haematology. 1997, Vol 10, Num 3, pp 561-576, issn 0950-3536Article